A low cost, flexible atmospheric pressure plasma jet device with good antimicrobial efficiency
Authors:
Fellype do Nascimento,
Aline da Graça Sampaio,
Noala Vicensoto Moreira Milhan,
Aline Vidal Lacerda Gontijo,
Philipp Mattern,
Torsten Gerling,
Eric Robert,
Cristiane Yumi Koga-Ito,
Konstantin Georgiev Kostov
Abstract:
Plasma sources suitable to generate low temperature plasmas has been fundamental for the advances in plasma medicine. In this research field, plasma sources must comply with stringent conditions for clinical applications. The main requirement to be met is the patient and operator's safety and the ethical requirement of effectivity, which encompasses the electrical regulations, potential device tox…
▽ More
Plasma sources suitable to generate low temperature plasmas has been fundamental for the advances in plasma medicine. In this research field, plasma sources must comply with stringent conditions for clinical applications. The main requirement to be met is the patient and operator's safety and the ethical requirement of effectivity, which encompasses the electrical regulations, potential device toxicity and effectiveness in relation to the desired treatment. All these issues are addressed by the German pre-standard DIN SPEC 91315:2014-06 (DINSpec), which deals with the safety limits, risk assessment and biological efficacy of plasma sources aimed for medical applications. In this work, a low cost, user-friendly and flexible atmospheric pressure plasma jet (APPJ) device was characterized following the DINSpec guidelines. The device, which is still under development, proved to be safe for medical applications. It is capable of producing an APPJ with low patient leakage current and UV emission, gas temperature lower than 40 °C, production of harmful gases within the safety limits and low cytotoxicity. The most differentiating feature is that the device presented good antimicrobial efficacy even operating at frequency of the order of just a few hundred Hz, a value below that of most devices reported in the literature.
△ Less
Submitted 5 January, 2024; v1 submitted 30 October, 2023;
originally announced October 2023.
